As of 2024-07-27, the EV/EBITDA ratio of Dicerna Pharmaceuticals Inc (DRNA) is -22.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DRNA's latest enterprise value is 2,729.79 mil USD. DRNA's TTM EBITDA according to its financial statements is -119.65 mil USD. Dividing these 2 quantities gives us the above DRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 21.5x | 16.6x |
| Forward P/E multiples | 17.8x - 24.1x | 21.4x |
| Fair Price | (25.93) - (31.77) | (27.82) |
| Upside | -167.8% - -183.1% | -172.8% |
| Date | EV/EBITDA |